Pulmonary embolism (PE) is a form of venous thromboembolism that has a devastating and potentially fatal clinical course with an array of symptoms and presentation that has become a cause of great concern to health professionals [1-3]. In the United Sates, the incidence of venous thromboembolism ranges from about 900,000 [1] which includes both Deep Vein Thrombosis and PE,